Title and authors | Publication | Year |
---|---|---|
CD8+ T cells directed against a neuron-restricted antigen surveil the healthy CNS and injure axons following demyelination.
Benjamin Clarkson, Ethan Grund, Miranda Standiford, Kanish Mirchia, Charles Howe |
Journal of Clinical Investigation | 2023 |
Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing Rag1 Knock-Out Mice
Kim SH, Go EM, Shin DH, Choi BK, Han C |
Cells | 2022 |
Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rαhi CD8+ T cells
SH Kim, E Cho, YI Kim, C Han, BK Choi, BS Kwon |
Nature Communications | 2021 |
Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor Model:
A Visioni, M Kim, C Wilfong, A Blum, C Powers, D Fisher, E Gabriel, J Skitzki |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2018 |
Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma.
Munger CM, Hegde GV, Weisenburger DD, Vose JM, Joshi SS |
Cancer Immunology, Immunotherapy | 2012 |
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
MA Geller, S Cooley, PL Judson, R Ghebre, LF Carson, PA Argenta, AL Jonson, A Panoskaltsis-Mortari, J Curtsinger, D McKenna, K Dusenbery, R Bliss, LS Downs, JS Miller |
Cytotherapy | 2011 |
Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy
E Proietti, F Moschella, I Capone, F Belardelli |
Molecular Oncology | 2011 |
Activating Systemic T-Cell Immunity Against Self Tumor Antigens to Support Oncolytic Virotherapy with Vesicular Stomatitis Virus
P Wongthida, RM Diaz, C Pulido, D Rommelfanger, F Galivo, K Kaluza, T Kottke, J Thompson, A Melcher, R Vile |
Human Gene Therapy | 2011 |
Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery
KS Gunturu, KR Meehan, TA Mackenzie, TS Crocenzi, D McDermott, EJ Usherwood, KA Margolin, NA Crosby, MB Atkins, MJ Turk, C Ahonen, S Fuse, JI Clark, JL Fisher, RJ Noelle, MS Ernstoff |
Journal of Clinical Oncology | 2010 |
Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatorycells
R Liu, S Xiong, L Zhang, Y Chu |
Cellular and Molecular Immunology | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
From the Cover: Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
DC Palmer, CC Chan, L Gattinoni, C Wrzesinski, CM Paulos, CS Hinrichs, DJ Powell, CA Klebanoff, SE Finkelstein, RN Fariss, Z Yu, RB Nussenblatt, SA Rosenberg, NP Restifo |
Proceedings of the National Academy of Sciences | 2008 |
Immunotherapy of malignant brain tumors
DA Mitchell, PE Fecci, JH Sampson |
Immunological Reviews | 2008 |
Hematopoietic stem cells promote the expansion and function of adoptively transferred anti-tumor CD8+ T cells
Claudia Wrzesinski, Chrystal M Paulos, Luca Gattinoni, Douglas C. Palmer, Andrew Kaiser , Zhiya Yu, Steven A. Rosenberg and Nicholas P. Restifo |
Journal of Clinical Investigation | 2007 |
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via toll-like receptor 4 signaling
Chrystal M. Paulos, Claudia Wrzesinski, Andrew Kaiser, Christian S. Hinrichs, Marcello Chieppa, Lydie Cassard, Douglas C. Palmer, Andrea Boni, Pawel Muranski, Zhiya Yu, Luca Gattinoni, Paul A. Antony, Steven A. Rosenberg, and Nicholas P. Restifo |
Journal of Clinical Investigation | 2007 |
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone
JS Miller, DJ Weisdorf, LJ Burns, A Slungaard, JE Wagner, MR Verneris, S Cooley, R Wangen, SK Fautsch, R Nicklow, T Defor, BR Blazar |
Blood | 2007 |
Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response
D Rüttinger, NK van den Engel, H Winter, M Schlemmer, H Pohla, S Grützner, B Wagner, DJ Schendel, BA Fox, KW Jauch, RA Hatz |
Journal of Translational Medicine | 2007 |
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction
Nechushtan H, Pham D, Zhang Y, Morgensztern D, Yi KH, Shin SU, Federoff HJ, Bowers WJ, Tolba KA, Rosenblatt JD |
Cancer Immunology, Immunotherapy | 2007 |
Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing
LX Wang, R Li, G Yang, M Lim, A O'Hara, Y Chu, BA Fox, NP Restifo, WJ Urba, HM Hu |
Cancer research | 2005 |
Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives
R Baccala, R Gonzalez-Quintial, W Dummer, AN Theofilopoulos |
Springer Seminars in Immunopathology | 2005 |
DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4 T cells and CD8 T cells
M Miyazaki, T Nakatsura, K Yokomine, S Senju, M Monji, S Hosaka, H Komori, Y Yoshitake, Y Motomura, M Minohara, T Kubo, K Ishihara, T Hatayama, M Ogawa, Y Nishimura |
Cancer Science | 2005 |
Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity.
Adler AJ |
Current immunology reviews | 2005 |
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.
Mihalyo MA, Doody AD, McAleer JP, Nowak EC, Long M, Yang Y, Adler AJ |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news?
R Handgretinger, W Leung, K Ihm, P Lang, T Klingebiel, D Niethammer |
British Journal of Cancer | 2003 |
Adoptive-cell-transfer therapy for the treatment of patients with cancer
ME Dudley, SA Rosenberg |
Nature Reviews Cancer | 2003 |